Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

According to a National Cancer Institute report, lung cancer incidence and mortality rates exceed national averages of 38.4 and 30.2 per 100,000 persons, respectively, in an 11-county region in ...

Lung cancer is the nation's deadliest cancer and advocates say the new screening program provides long-awaited hope. What's next? The program aims to save 12,000 lives over the next decade.

The program, which began in 2013 with just seven screenings, has now conducted over 50,000 screenings. Dr. Gieske shared the impact of these efforts: "We've now found over 500 stage 1 lung cancers ...

AstraZeneca’s AI lung cancer screening program executes 5 mn tests, flags 50k individuals at high risk The screen program is part of the World Economic Forum's EDISON alliance 1 billion lives ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access. In this clip, Raymond Osarogiagbon, MD ...

One-time screening flagged 19.2% of participants in the prospective study and led to biopsy-proven lung cancer diagnosis in 1.7% (200 of 11,708), reported Wenhua Liang, MD, of the First Affiliated ...

HealthDay News — Among individuals eligible for lung cancer screening (LCS), use of breast cancer screening (BCS) and colorectal cancer screening (CCS) is much higher than use of LCS, according ...

Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, only 18% of eligible individuals in the U.S. get screened.

Although lung cancer screening is recommended in the U.S. for certain individuals with a history of smoking, only 18% of eligible individuals in the U.S. get screened.

The researchers found that 15.4% of the 17,101 participants underwent screening before the guideline change compared with 47.1% after.